AXS-05 Results in Reduction in Major Depression Symptoms

Jennifer E. Engen

New data indicates a positive future for AXS-05 (dextromethorphan-bupropion) as a potential treatment for patients with major depressive disorder. The drug, developed by Axsome Therapeutics, is a novel, oral investigational N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity. The results from the GEMINI phase 3 clinical trial show AXS-05 showed rapid, […]

Patients Receiving Virta’s Diabetes Reversal Treatment See Sustained Reduction in Depressive Symptoms, New Research Shows

Jennifer E. Engen

SAN FRANCISCO–(BUSINESS WIRE)–Virta Health, the leader in type 2 diabetes reversal, announced promising results on the impact of its diabetes reversal treatment on depressive symptoms. The research, published in The Journal of Behavioral Medicine, highlights rapid and sustained improvement in depressive symptoms during treatment, with nearly one-third fewer patients meeting […]